Vanguard Group Inc. Has $1.56 Billion Position in Docusign Inc. $DOCU

Vanguard Group Inc. grew its position in Docusign Inc. (NASDAQ:DOCU) by 1.1% in the third quarter, HoldingsChannel.com reports. The fund owned 21,625,551 shares of the company’s stock after buying an additional 225,525 shares during the period. Vanguard Group Inc. owned about 0.11% of Docusign worth $1,558,986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Norges Bank bought a new stake in shares of Docusign in the 2nd quarter valued at about $140,987,000. Third Point LLC bought a new position in Docusign during the second quarter worth about $48,681,000. Jupiter Asset Management Ltd. increased its position in Docusign by 88.3% during the second quarter. Jupiter Asset Management Ltd. now owns 1,316,440 shares of the company’s stock worth $102,538,000 after buying an additional 617,200 shares during the last quarter. Alliancebernstein L.P. raised its stake in Docusign by 132.8% in the second quarter. Alliancebernstein L.P. now owns 868,531 shares of the company’s stock valued at $67,650,000 after buying an additional 495,380 shares during the period. Finally, Nippon Life Global Investors Americas Inc. raised its stake in Docusign by 134.1% in the third quarter. Nippon Life Global Investors Americas Inc. now owns 508,590 shares of the company’s stock valued at $36,664,000 after buying an additional 291,380 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Docusign Price Performance

Shares of NASDAQ DOCU opened at $44.48 on Friday. The stock’s fifty day moving average price is $58.57 and its two-hundred day moving average price is $67.59. Docusign Inc. has a one year low of $41.53 and a one year high of $94.67. The firm has a market cap of $8.91 billion, a price-to-earnings ratio of 31.10, a P/E/G ratio of 1.93 and a beta of 1.00.

Insider Buying and Selling

In related news, insider James P. Shaughnessy sold 12,000 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the transaction, the insider directly owned 54,550 shares in the company, valued at approximately $3,656,486.50. This represents a 18.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Allan C. Thygesen sold 26,250 shares of the firm’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $69.60, for a total transaction of $1,827,000.00. Following the transaction, the chief executive officer directly owned 142,261 shares in the company, valued at approximately $9,901,365.60. This represents a 15.58% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 78,292 shares of company stock valued at $5,374,260 in the last 90 days. 1.01% of the stock is currently owned by corporate insiders.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Bonterms launched a DocuSign IAM extension app, which could increase platform stickiness and partner-driven adoption for DocuSign’s e-signature workflows. Bonterms Launches DocuSign IAM Extension App
• Positive Sentiment: Zacks published bullish/value-oriented analysis arguing DocuSign is a long-term value pick, which can support investor interest from value-focused funds. Why DocuSign is a Top Value Stock for the Long-Term
• Neutral Sentiment: Comparative pieces (DOCU vs ADYEY) and a Benzinga analyst-rating roundup provide context but are unlikely to move shares dramatically by themselves. DOCU vs. ADYEY: Which Stock Is the Better Value Option?
• Neutral Sentiment: A Benzinga deep-dive summarizes 12 analyst ratings — useful for context but not a single, market-moving consensus. Deep Dive Into DocuSign Stock: Analyst Perspectives
• Neutral Sentiment: Reported short-interest data shows odd/zero values and a 0.0 days-to-cover figure, which appears to be a data reporting anomaly rather than a clear signal of rising bearish positioning.
• Negative Sentiment: HSBC’s Stephen Bersey reiterated a Hold and cut his price target from $77 to $53, citing weaker growth prospects — a clear negative for sentiment and expectations. What Makes Docusign (DOCU) Attractive
• Negative Sentiment: BTIG trimmed its price target (reported ahead of earnings commentary), another sign analysts are moderating expectations for near-term performance. BTIG Lowers DocuSign Price Target to $70
• Negative Sentiment: Recent market-coverage notes and headlines highlight that DOCU has underperformed the broader market in recent sessions, reinforcing downside momentum. DocuSign Suffers a Larger Drop Than the General Market
• Negative Sentiment: Technically, DOCU is trading well below its 50- and 200-day moving averages, which may keep momentum traders and some funds sidelined until near-term trends improve.

Analyst Ratings Changes

DOCU has been the subject of several research analyst reports. Cantor Fitzgerald reiterated an “outperform” rating on shares of Docusign in a research note on Wednesday, December 17th. HSBC set a $53.00 price target on Docusign in a report on Friday, February 13th. Bank of America decreased their price objective on shares of Docusign from $102.00 to $82.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research report on Wednesday, December 17th. Finally, Wells Fargo & Company cut their target price on shares of Docusign from $85.00 to $75.00 and set an “equal weight” rating for the company in a research note on Friday, December 5th. Six research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $82.80.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.